| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Gibson Christopher is a Director at RXRX, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 213 sales.
Our model assigns Gibson Christopher a strong insider score of 70/100, based on 87 past trades. Over a 12-month horizon, 80.3% of those trades were profitable, with an average 12-month return of +17.4%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell10b5-1 | 40,000 | $3.62 | $144,800.00 | -4.3% | +3.8% | - | |
| May 22, 2026 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell10b5-1 | 40,000 | $3.08 | $123,200.00 | -4.3% | +11.0% | - | |
| May 7, 2026 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell10b5-1 | 40,000 | $3.37 | $134,800.00 | -4.1% | -3.1% | - | |
| Apr 22, 2026 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell10b5-1 | 40,000 | $3.61 | $144,400.00 | -4.2% | -17.4% | - | |
| Apr 7, 2026 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell10b5-1 | 40,000 | $3.10 | $124,000.00 | -4.2% | +24.1% | - | |
| Mar 23, 2026 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell10b5-1 | 40,000 | $3.25 | $130,000.00 | -4.2% | -1.5% | - | |
| Feb 19, 2026 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell10b5-1 | 40,000 | $3.46 | $138,400.00 | -4.2% | -20.4% | - | |
| Feb 4, 2026 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell10b5-1 | 40,000 | $4.12 | $164,800.00 | -4.2% | -13.6% | - | |
| Jan 20, 2026 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell10b5-1 | 40,000 | $4.47 | $178,800.00 | -4.2% | -16.1% | - | |
| Jan 5, 2026 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell10b5-1 | 40,000 | $4.25 | $170,000.00 | -4.1% | -27.9% | - |